You won't see as many large swings in prices as you have in the past for drugs billed to Medicare starting July 1. The average sales price (ASP) calculations remain relatively stable for the third quarter, with prices increasing less than 1% on average, according to an exclusive analysis of the CMS's quarterly ASP drug list by Part B News.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.